ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00736372
Recruitment Status : Completed
First Posted : August 15, 2008
Last Update Posted : May 17, 2018
Sponsor:
Information provided by (Responsible Party):
Seattle Genetics, Inc. ( Cascadian Therapeutics Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : August 2009